Gartner Inc vs Sana Biotechnology Inc — how do they compare? Gartner Inc trades at $187.99 (market cap $11.83B), while Sana Biotechnology Inc trades at $3.78 (market cap $1.13B). The key difference: Gartner Inc is far larger — about 10.5× Sana Biotechnology Inc's market cap, and Gartner Inc is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| IT | SANA | |
|---|---|---|
Market Cap | $11.83B | $1.13B |
Sector | Technology | Health |
52-Week High | $264.09 | $5.92 |
52-Week Low | $125.68 | $2.68 |
Enterprise Value | $13.57B | $1.05B |
Trailing returns across standard periods
Based in Stamford, Conn., Gartner provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services and hosted nearly 80 IT conferences across the globe in 2007.
Read more on IT →Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →